In our current era of rapidly developing cancer drugs
and therapies, we also see improvement of cancer treatment outcomes
stagnating when it comes to determining quality of life or
long-term survival. This is because while new treatments are making
small incremental progress in outcomes, most cancer patients still
depend on conventional methods that are both toxic and ineffective.
While new cancer drugs are becoming more precise or targeted, less... more...